Segment Reporting (Tables)

9 Months Ended

Sep. 30, 2022

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment

Financial information relating to our reportable operating segments and reconciliations to the consolidated totals for the three and nine-month periods ended September 30, 2022 and 2021, were as follows (in thousands):

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2022		2021		2022		2021
Net sales
Cardiovascular	$	278,949	$	259,704	$	832,555	$	773,002
Endoscopy		8,226		7,317		25,011		23,257
Total net sales		287,175		267,021		857,566		796,259
Income from operations
Cardiovascular		17,435		14,411		51,836		33,389
Endoscopy		1,222		1,520		5,310		5,631
Total income from operations		18,657		15,931		57,146		39,020
Total other expense — net		(1,055)		(1,754)		(4,672)		(5,284)
Income tax expense		2,330		2,210		11,359		5,895
Net income	$	15,272	$	11,967	$	41,115	$	27,841